Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New National Survey: Americans Agree Patients Should Have Treatment Options for Opioid Addiction. Fewer Than Half in Recovery Were Offered More Than One

Mobilize Recovery

News provided by

Mobilize Recovery

Sep 22, 2026, 08:30 ET

Share this article

Share toX

Share this article

Share toX

National survey of 1,076 U.S. adults, including 304 adults in recovery from opioid addiction

Drug addiction ranks second only to mental illness as top U.S. health challenge, ahead of obesity, cancer, heart disease and diabetes

78% of adults in recovery say elected officials are paying at least as much attention to the opioid crisis as five years ago, compared with 54% of the general public

LAS VEGAS, Sept. 22, 2026 /PRNewswire/ -- Mobilize Recovery today announced results of a new national survey showing that drug addiction ranks among the two most serious health problems facing the country, named by 41% of the general public and 51% of adults in recovery. It trailed only mental illness and ranked ahead of obesity, cancer, heart disease and diabetes. Adults in recovery were far more likely to say elected officials are paying at least as much attention to the opioid crisis as five years ago (78% vs. 54% of the general public).

The survey segmented responses by general public (n = 772) and people in recovery from opioid addiction (n = 304) and compared both groups on the same questions. The highest rated statement for both groups was that treatment that fits an individual's circumstances could be valuable (89% general public; 93% recovery). Also nearly unanimous was the view that patients and doctors should be able to weigh more than one treatment option (88% general public; 92% recovery). The reality was different. Among adults in recovery, 44% said a provider discussed one option or none with them, and another 10% never saw a provider.

"These findings show that too many patients still aren't getting a real choice," said Ryan Hampton, co-founder of Mobilize Recovery. "Nearly half of people in recovery said their provider discussed just one treatment option or none. People can't weigh an option they never hear about. We have to do better at making sure those conversations happen."

Where both groups further agreed:

  • Stigma about medication persists in both groups and runs deepest inside the recovery community. Only 35% of the general public and 39% of people in recovery described medication for opioid addiction as a legitimate treatment for a medical condition. Roughly a third of each group saw medication as temporary, 33% of the general public and 34% of people in recovery, saying it can help but should eventually be stopped. The most critical view was more common among people in recovery, where 22% said medication "replaces one dependency with another," compared with 15% of the general public.
  • Family and medication named as the top two supports. When asked what type of support makes the biggest difference in helping someone in recovery, 26% of the general public named family support, and 19% named medication. Among people in recovery, 23% named medication and 19% said family, effectively making these two tied at the top.
  • Unanimous that paperwork should not cost someone their treatment. Exactly 55% of the general public and 55% of people in recovery strongly agreed that a person actively in treatment for opioid addiction should not lose Medicaid coverage because of a paperwork or reporting error. 84% of the general public and 89% of people in recovery said maintaining coverage and continuity of care matters for someone in active treatment.

Where views differed the most:

  • People in recovery want the federal response to be aimed at attitudes, not just capacity. The general public led with expanding treatment availability (60% general public; 47% recovery) and more recovery support services (56% general public; 44% recovery). People in recovery ranked increasing public understanding of addiction (35% general public; 48% recovery) and successful reentry after incarceration (24% general public; 40% recovery) much higher.
  • People in recovery have a more optimistic view of the opioid crisis than the public. 44% of adults in recovery said the opioid crisis has gotten better over the past five years, versus 18% of the general public. A quarter of people in recovery (24%) said it has gotten much better, compared with 4% of the general public.
  • The public may not see the insurance barriers that patients run into. Among adults in recovery who used medication, 53% said an insurer delayed or denied coverage for their treatment. Asked whether people seeking treatment usually face delays, 34% of the general public said yes and 48% said they were not sure.

"I'm encouraged that people in recovery are feeling hopeful," Hampton continued. "When you've seen treatment work in your own life, you believe it can work for someone else, too. But hope is not the same as progress. More than 44,000 people died of an opioid overdose last year, and fewer than one in five people with opioid use disorder receive medication to treat it. Heading into November, policymakers have an opportunity to show how they will keep people connected to care, widen treatment choice and turn lives saved into lasting recovery."

The findings arrive in the 50th year of the modern recovery movement and during National Recovery Month. Mobilize Recovery will use them in its ongoing advocacy work. The findings are available in further detail here.

Survey Methodology

The national survey of U.S. adults was fielded Aug. 14–18, 2026, and included 1,076 completed interviews: 772 respondents in the general population and an oversample of 304 adults who identified as being in recovery from opioid addiction. Medications for opioid use disorder (MOUD) include methadone, buprenorphine and naltrexone, available in different formulations and dosing approaches. Results were weighted to national benchmarks, with the general population weighted to Census (ACS) benchmarks and the recovery sample scaled to National Survey on Drug Use and Health (NSDUH) prevalence estimates. The margin of error for the full sample is +/-3.7 percentage points and is larger for subgroups. Findings among adults in recovery are reported on an unweighted base of 304. The survey was commissioned by Mobilize Recovery, conducted by G2 Analytics and funded by Indivior.

About Mobilize Recovery

Mobilize Recovery is a national 501(c)(3) nonprofit organization dedicated to raising up the voices of people whose lives are affected by addiction. The organization empowers advocates to take direct action by providing tools, training and education. Learn more on the Mobilize Recovery website, Instagram, Facebook, X, TikTok, or sign up for email updates.

Media Contact
Sarah Farinelli
843-377-6610
[email protected]

SOURCE Mobilize Recovery

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.